MonTa Biosciences

MonTa Biosciences is an immuno-oncology company with our main asset being a TLR7 formulation.

We have demonstrated antitumor activity in monotherapy and combination with immune checkpoint inhibitors, radiotherapy and chemotherapy. We are in the development phase with ongoing CMC activity and toxicology studies and expect to initiate phase I by Q1 2021.

Contact name:

Simon Jensen

Address:

Diplomvej 381, 2800 Kgs. Lyngby

Telephone:

51186306

Established:

2015

Number of employees:

4

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2019 Danskbiotek. All rights reserved.